CARDIOVASCULAR RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=800689, encodeId=cfef80068995, content=今年被JCR温和警告，少数文章引用过高，提示可能有异常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Tue Jun 30 23:33:46 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913869, encodeId=18a2913869a0, content=祝贺荣升一区，好杂志! 在这期刊上发一篇对自身提高帮助很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Tue Jan 05 13:38:09 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469282, encodeId=353946928268, content=国内做基础的人投心血管领域的，最多的是 cardiovascular research，JMCC，AJP旗下的心血管杂志，这三个杂志的频率最高。当然另外heart, heart Journal也有一些。另外，这个杂志有时会搞专题，这时候特别好投稿，不过要把握好时机，有时专题时，文章稿量不足，稍次一些稿件也可以发了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 12:51:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893896, encodeId=467d89389690, content=新一年是不是该一区了，之前中了一篇，最近的一个工作一轮就拒了，然后工作发在了一个10分左右的一区杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Fri Oct 23 07:38:59 CST 2020, time=2020-10-23, status=1, ipAttribution=)]

2025-04-10 ms5000001778422266 来自湖北省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：心脏瓣膜材料综述
经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=800689, encodeId=cfef80068995, content=今年被JCR温和警告，少数文章引用过高，提示可能有异常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Tue Jun 30 23:33:46 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913869, encodeId=18a2913869a0, content=祝贺荣升一区，好杂志! 在这期刊上发一篇对自身提高帮助很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Tue Jan 05 13:38:09 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469282, encodeId=353946928268, content=国内做基础的人投心血管领域的，最多的是 cardiovascular research，JMCC，AJP旗下的心血管杂志，这三个杂志的频率最高。当然另外heart, heart Journal也有一些。另外，这个杂志有时会搞专题，这时候特别好投稿，不过要把握好时机，有时专题时，文章稿量不足，稍次一些稿件也可以发了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 12:51:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893896, encodeId=467d89389690, content=新一年是不是该一区了，之前中了一篇，最近的一个工作一轮就拒了，然后工作发在了一个10分左右的一区杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Fri Oct 23 07:38:59 CST 2020, time=2020-10-23, status=1, ipAttribution=)]

2025-04-10 ms5000001778422266 来自湖北省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：心脏瓣膜材料综述
经验分享：投稿综述
3月19 submitted to journal
3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。
有经历过的大佬吗，求解答，

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=800689, encodeId=cfef80068995, content=今年被JCR温和警告，少数文章引用过高，提示可能有异常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Tue Jun 30 23:33:46 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913869, encodeId=18a2913869a0, content=祝贺荣升一区，好杂志! 在这期刊上发一篇对自身提高帮助很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Tue Jan 05 13:38:09 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469282, encodeId=353946928268, content=国内做基础的人投心血管领域的，最多的是 cardiovascular research，JMCC，AJP旗下的心血管杂志，这三个杂志的频率最高。当然另外heart, heart Journal也有一些。另外，这个杂志有时会搞专题，这时候特别好投稿，不过要把握好时机，有时专题时，文章稿量不足，稍次一些稿件也可以发了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 12:51:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893896, encodeId=467d89389690, content=新一年是不是该一区了，之前中了一篇，最近的一个工作一轮就拒了，然后工作发在了一个10分左右的一区杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Fri Oct 23 07:38:59 CST 2020, time=2020-10-23, status=1, ipAttribution=)]

2025-01-23 白衣13 来自新南威尔士

1.10 投稿
1.15 改格式
1.17 with editor
1.22 under review
这里的under review是外审吗？还是只是编辑内审呢？

24 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=800689, encodeId=cfef80068995, content=今年被JCR温和警告，少数文章引用过高，提示可能有异常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Tue Jun 30 23:33:46 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913869, encodeId=18a2913869a0, content=祝贺荣升一区，好杂志! 在这期刊上发一篇对自身提高帮助很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Tue Jan 05 13:38:09 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469282, encodeId=353946928268, content=国内做基础的人投心血管领域的，最多的是 cardiovascular research，JMCC，AJP旗下的心血管杂志，这三个杂志的频率最高。当然另外heart, heart Journal也有一些。另外，这个杂志有时会搞专题，这时候特别好投稿，不过要把握好时机，有时专题时，文章稿量不足，稍次一些稿件也可以发了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 12:51:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893896, encodeId=467d89389690, content=新一年是不是该一区了，之前中了一篇，最近的一个工作一轮就拒了，然后工作发在了一个10分左右的一区杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Fri Oct 23 07:38:59 CST 2020, time=2020-10-23, status=1, ipAttribution=)]

2023-02-24 759706283 来自陕西省

请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗

215 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=800689, encodeId=cfef80068995, content=今年被JCR温和警告，少数文章引用过高，提示可能有异常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Tue Jun 30 23:33:46 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913869, encodeId=18a2913869a0, content=祝贺荣升一区，好杂志! 在这期刊上发一篇对自身提高帮助很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Tue Jan 05 13:38:09 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469282, encodeId=353946928268, content=国内做基础的人投心血管领域的，最多的是 cardiovascular research，JMCC，AJP旗下的心血管杂志，这三个杂志的频率最高。当然另外heart, heart Journal也有一些。另外，这个杂志有时会搞专题，这时候特别好投稿，不过要把握好时机，有时专题时，文章稿量不足，稍次一些稿件也可以发了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 12:51:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893896, encodeId=467d89389690, content=新一年是不是该一区了，之前中了一篇，最近的一个工作一轮就拒了，然后工作发在了一个10分左右的一区杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Fri Oct 23 07:38:59 CST 2020, time=2020-10-23, status=1, ipAttribution=)]

2024-08-20 1464e744m37暂无昵称来自四川省

revision submitted to journal 16天了，好慢

212 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=800689, encodeId=cfef80068995, content=今年被JCR温和警告，少数文章引用过高，提示可能有异常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Tue Jun 30 23:33:46 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913869, encodeId=18a2913869a0, content=祝贺荣升一区，好杂志! 在这期刊上发一篇对自身提高帮助很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Tue Jan 05 13:38:09 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469282, encodeId=353946928268, content=国内做基础的人投心血管领域的，最多的是 cardiovascular research，JMCC，AJP旗下的心血管杂志，这三个杂志的频率最高。当然另外heart, heart Journal也有一些。另外，这个杂志有时会搞专题，这时候特别好投稿，不过要把握好时机，有时专题时，文章稿量不足，稍次一些稿件也可以发了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 12:51:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893896, encodeId=467d89389690, content=新一年是不是该一区了，之前中了一篇，最近的一个工作一轮就拒了，然后工作发在了一个10分左右的一区杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Fri Oct 23 07:38:59 CST 2020, time=2020-10-23, status=1, ipAttribution=)]

2023-02-10 wslyxblxx 来自河南省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！

361 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=800689, encodeId=cfef80068995, content=今年被JCR温和警告，少数文章引用过高，提示可能有异常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Tue Jun 30 23:33:46 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913869, encodeId=18a2913869a0, content=祝贺荣升一区，好杂志! 在这期刊上发一篇对自身提高帮助很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Tue Jan 05 13:38:09 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469282, encodeId=353946928268, content=国内做基础的人投心血管领域的，最多的是 cardiovascular research，JMCC，AJP旗下的心血管杂志，这三个杂志的频率最高。当然另外heart, heart Journal也有一些。另外，这个杂志有时会搞专题，这时候特别好投稿，不过要把握好时机，有时专题时，文章稿量不足，稍次一些稿件也可以发了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 12:51:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893896, encodeId=467d89389690, content=新一年是不是该一区了，之前中了一篇，最近的一个工作一轮就拒了，然后工作发在了一个10分左右的一区杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Fri Oct 23 07:38:59 CST 2020, time=2020-10-23, status=1, ipAttribution=)]

2020-06-30 mswert122

今年被JCR温和警告，少数文章引用过高，提示可能有异常

659 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=800689, encodeId=cfef80068995, content=今年被JCR温和警告，少数文章引用过高，提示可能有异常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Tue Jun 30 23:33:46 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913869, encodeId=18a2913869a0, content=祝贺荣升一区，好杂志! 在这期刊上发一篇对自身提高帮助很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Tue Jan 05 13:38:09 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469282, encodeId=353946928268, content=国内做基础的人投心血管领域的，最多的是 cardiovascular research，JMCC，AJP旗下的心血管杂志，这三个杂志的频率最高。当然另外heart, heart Journal也有一些。另外，这个杂志有时会搞专题，这时候特别好投稿，不过要把握好时机，有时专题时，文章稿量不足，稍次一些稿件也可以发了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 12:51:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893896, encodeId=467d89389690, content=新一年是不是该一区了，之前中了一篇，最近的一个工作一轮就拒了，然后工作发在了一个10分左右的一区杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Fri Oct 23 07:38:59 CST 2020, time=2020-10-23, status=1, ipAttribution=)]

2021-01-05 小小研究人员

祝贺荣升一区，好杂志! 在这期刊上发一篇对自身提高帮助很大。

609 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=800689, encodeId=cfef80068995, content=今年被JCR温和警告，少数文章引用过高，提示可能有异常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Tue Jun 30 23:33:46 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913869, encodeId=18a2913869a0, content=祝贺荣升一区，好杂志! 在这期刊上发一篇对自身提高帮助很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Tue Jan 05 13:38:09 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469282, encodeId=353946928268, content=国内做基础的人投心血管领域的，最多的是 cardiovascular research，JMCC，AJP旗下的心血管杂志，这三个杂志的频率最高。当然另外heart, heart Journal也有一些。另外，这个杂志有时会搞专题，这时候特别好投稿，不过要把握好时机，有时专题时，文章稿量不足，稍次一些稿件也可以发了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 12:51:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893896, encodeId=467d89389690, content=新一年是不是该一区了，之前中了一篇，最近的一个工作一轮就拒了，然后工作发在了一个10分左右的一区杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Fri Oct 23 07:38:59 CST 2020, time=2020-10-23, status=1, ipAttribution=)]

2009-09-30 匿名用户

国内做基础的人投心血管领域的，最多的是 cardiovascular research，JMCC，AJP旗下的心血管杂志，这三个杂志的频率最高。当然另外heart, heart Journal也有一些。另外，这个杂志有时会搞专题，这时候特别好投稿，不过要把握好时机，有时专题时，文章稿量不足，稍次一些稿件也可以发了。

414 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259893, encodeId=e9cf2259893e8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：综述投稿 3月19 submitted to journal 3月27 直接就是Decision in Progress，这是什么意思，而且现在已经半个月还是Decision in Progress。有没有大佬经历过，求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:38:26 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2259889, encodeId=b6b722598892c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心脏瓣膜材料综述 经验分享：投稿综述 3月19 submitted to journal 3月27 直接就是Decision in Progress是什么意思，而且现在已经半个月了，还是Decision in Progress。 有经历过的大佬吗，求解答，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8599517450, createdName=ms5000001778422266, createdTime=Thu Apr 10 11:25:20 CST 2025, time=2025-04-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2249259, encodeId=32242249259d2, content=1.10 投稿 1.15 改格式 1.17 with editor 1.22 under review 这里的under review是外审吗？还是只是编辑内审呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Thu Jan 23 07:54:07 CST 2025, time=2025-01-23, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2116289, encodeId=9ad2211628998, content=请问投了以后2月15 显示 with eidtor ，然后更新了日期2月21日，但是还是显示 with eidtor。这是代表还没送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Fri Feb 24 15:40:31 CST 2023, time=2023-02-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2221616, encodeId=a3e1222161693, content=revision submitted to journal 16天了，好慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae035128370, createdName=1464e744m37暂无昵称, createdTime=Tue Aug 20 23:42:56 CST 2024, time=2024-08-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2113953, encodeId=a2762113953ec, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：心血管领域非常专业的杂志，认可度高。从投稿到接收用了5个月。重视动物实验和详细的机制，创新性强时数据量不大也可发表。杂志会邀请客座编辑对文章进行评估，一般都是领域内的大牛。外审意见返回后，客座编辑会综合意见并提出自己的看法和要求。杂志有专门的团队帮忙润色，水平非常高！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0da81966598, createdName=wslyxblxx, createdTime=Fri Feb 10 12:58:06 CST 2023, time=2023-02-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=800689, encodeId=cfef80068995, content=今年被JCR温和警告，少数文章引用过高，提示可能有异常, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Tue Jun 30 23:33:46 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913869, encodeId=18a2913869a0, content=祝贺荣升一区，好杂志! 在这期刊上发一篇对自身提高帮助很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Tue Jan 05 13:38:09 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469282, encodeId=353946928268, content=国内做基础的人投心血管领域的，最多的是 cardiovascular research，JMCC，AJP旗下的心血管杂志，这三个杂志的频率最高。当然另外heart, heart Journal也有一些。另外，这个杂志有时会搞专题，这时候特别好投稿，不过要把握好时机，有时专题时，文章稿量不足，稍次一些稿件也可以发了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 30 12:51:00 CST 2009, time=2009-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893896, encodeId=467d89389690, content=新一年是不是该一区了，之前中了一篇，最近的一个工作一轮就拒了，然后工作发在了一个10分左右的一区杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/26/51d93230578b77b132b8396731cdd3a0.jpg, createdBy=a40c2047950, createdName=小小研究人员, createdTime=Fri Oct 23 07:38:59 CST 2020, time=2020-10-23, status=1, ipAttribution=)]

2020-10-23 小小研究人员

新一年是不是该一区了，之前中了一篇，最近的一个工作一轮就拒了，然后工作发在了一个10分左右的一区杂志。

870 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务